Diagnostic Medical Systems S.A.
Diagnostic Medical Systems S.A. (ALDMS.PA) Stock Overview
Explore Diagnostic Medical Systems S.A.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
27.1M
P/E Ratio
-8.58
EPS (TTM)
$-0.13
ROE
-0.25%
ALDMS.PA Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Diagnostic Medical Systems S.A. (ALDMS.PA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 60.50, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.77.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -8.58 and a market capitalization of 27.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
Diagnostic Medical Systems S.A. operates in the medical imaging industry in France and internationally. The company offers radiography/fluoroscopy, retrofit kits, mammography, chest and bone rooms, mobiles, bone densitometry, 3D reconstruction, and mobile C-arms solutions. It also provides technologies for the treatment of osteoarthritis, and regenerative medicine based on the injection of fat stem cells. Diagnostic Medical Systems S.A. was founded in 1979 and is based in Mauguio, France.
Samuel Sancerni
129
393 rue Charles Lindbergh, Mauguio
2000